Premalignant Clonal Hematopoietic Proliferations

Area of Science:

• Hematopathology
• Hematology
• Oncology

Background:

• Advances in immunophenotyping and genetic studies increasingly detect small clonal populations in asymptomatic individuals.
• These findings represent premalignant clonal hematopoietic proliferations of myeloid and lymphoid lineages.
• Conditions include monoclonal gammopathy of uncertain significance, monoclonal B-cell lymphocytosis, and clonal hematopoiesis of indeterminate potential.

Purpose of the Study:

• To review and discuss premalignant clonal hematopoietic proliferations.
• To establish consensus diagnoses for challenging cases.
• To evaluate current diagnostic criteria for these conditions.

Main Methods:

• A panel reviewed 27 cases of clonal proliferations of indeterminate significance or potential.
• Cases included both myeloid (18) and lymphoid (9) types.
• Consensus diagnoses were established based on provided case data.

Main Results:

• The workshop successfully rendered consensus diagnoses for the reviewed cases.
• Key premalignant conditions discussed include monoclonal gammopathy of uncertain significance, monoclonal B-cell lymphocytosis, in situ follicular neoplasia, in situ mantle cell neoplasia, clonal hematopoiesis of indeterminate potential, and clonal cytopenia of undetermined significance.
• The incidental detection of these clonal populations in asymptomatic individuals was highlighted.

Conclusions:

• Current diagnostic criteria for premalignant clonal hematopoietic proliferations were reviewed and discussed.
• The workshop provided valuable insights into the diagnosis and management of these evolving entities.
• Understanding these conditions is crucial for accurate prognostication and patient care.